Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Clinically observed concomitant decreases in serum ALT/AST and increases in peripheral blood mitochondrial DNA copy number highlight its in vivo bioactivity
Compound identity at a glance Name: Retatrutide INN: LY3437943 Class: Triple incretin receptor agonist Structure: 39-amino-acid synthetic peptide Dosing interval: Once weekly (research protocols) Developer: Eli Lilly For the full molecular reference (molecular formula, molecular weight, CAS number and the 39-amino-acid sequence) see the Retatrutide molecular profile
10.2147/IJGM.S15618 36 GiustariniD.ColomboG.GaravagliaM
Cost and accessibility The cost of NAD+ IV therapy can vary considerably
US$ 27.03
US$ 26.24
US$ 27.26
US$ 20.06
US$ 26.04
US$ 29.68
US$ 24.73
